Mikko Pietila, MD, PhD

Original Contribution

Gender-Based Analysis of the 3-Year Outcome of Bioactive Stents Versus Paclitaxel-Eluting Stents in Patients with Acute Myocardial Infarction: An Insight from the TITAX-AMI Trial

02/29/2012

Matti Niemela , MD, PhD;

Kari Kervinen , MD, PhD;

Mikko Pietila , MD, PhD;

Jussi Sia , MD;

Kai Nyman , MD;

Wail Nammas , MD, PhD;

Antti Ylitalo , MD, PhD;

Pasi P. Karjalainen , MD, PhD;

Juhani K.E. Airaksinen , MD, PhD, FESC;

Petri O. Tuomainen , MD, PhD;

Abstract: Background. The TITAX-AMI trial demonstrated a better clinical outcome of titanium-nitride-oxide-coated bioactive stents (BAS) as compared with paclitaxel-eluting stents (PES) in patients with acute myocardial infarction (MI)...

Abstract: Background. The...

02/29/2012

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Mikko Pietila, MD, PhD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products